tirzepatide protein intake optimization research on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Nutrition-First Support for GLP-1 and
Description
Feb 26, 2026 What if the problem is not your tirzepatide dose, but how you are delivering it
The severe side effects of Mounjaro are not common, but they can occur
together they regulate insulin, glucagon, appetite, and gastric motility
Initiation of GLP1 use with a patientcentered approach The approach to initiating pharmacologic therapy for obesity should be individualized, with a focus on overall physical health, mental health, and wellbeing rather than body weight alone
